JP Morgan Initiates Halozyme Therapeutics With Outperform By: Benzinga via Benzinga July 11, 2014 at 07:54 AM EDT Analysts at JP Morgan initiated coverage on Halozyme Therapeutics (NASDAQ: HALO) with a Outperform rating. The target price for ... Read More >> Related Stocks: Halozyme Therapeutic